ÃֽŠÀÇ°úÇÐ ¿¬±¸µ¿Ç⠺м® : KMbase 2019³â 4¿ù Å°¿öµå µ¿ÇâºÐ¼®
Çѱ¹ÀÇÇÐ³í¹®µ¥ÀÌÅͺ£À̽º(KMbase) 2019³â 4¿ù ÃֽŠÀÇ°úÇÐ ¿¬±¸µ¿ÇâÀ» ÆľÇÇϱâ À§ÇÏ¿© ±âÃÊÀÇÇÐ, ÀÓ»óÀÇÇÐ, ¿¹¹æÀÇÇÐ/º¸°ÇÇÐ, °£È£ÇÐ, Ä¡ÀÇÇко߸¦ Æ÷ÇÔÇÑ 6°³ ºÐ¾ßÀÇ Å°¿öµå ºÐ¼®À» ¼öÇàÇÏ¿´´Ù. KMbase¸¦ ÅëÇÏ¿© ÃßÃâµÈ Çѱ¹ÀÎ ¿¬±¸ÀÚ°¡ 2019³â 4¿ù¿¡ ±¹³»¿Í ±¹¿Ü Àú³Î¿¡ ¹ßÇ¥µÈ ³í¹®À» ºÐ¼®´ë»óÀ¸·Î ÇÏ¿´À¸¸ç ±â°£Àº 2019³â 4¿ù 1ÀϺÎÅÍ 30ÀϱîÁö ±¹³» ¹× ±¹¿Ü(PubMed ±âÁØ) Àú³Î¿¡ ¹ßÇ¥µÈ KMbase¿Í PubMed¸¦ ÅëÇÏ¿© µ¥ÀÌÅ͸¦ ÃßÃâÇÏ¿´´Ù.
±¹³» ¿¬±¸ÀÚ°¡ ¹ßÇ¥ÇÑ 2019³â 4¿ù Àüü ÀÇ°úÇкоßÀÇ ³í¹®Àº ±¹³»¹ßÇ¥ 1,444Æí, ±¹¿Ü¹ßÇ¥(PubMed±âÁØ) 2,071ÆíÀ¸·Î, ±¹³»,¿Ü¸¦ Æ÷ÇÔÇÏ¿© Àüü ÀÇ°úÇкоßÀÇ 3,515ÆíÀ» ºÐ¼® ´ë»óÀ¸·Î ÇÏ¿´´Ù. ÀÌ´Â 3¿ù 3,947Æí¿¡ ºñ±³ÇÏ¸é ¾à 10.9%°¡ °¨¼ÒÇÏ¿´À¸¸ç, 4¿ù Àüü ÀÇ°úÇÐºÐ¾ß ¹ßÇ¥ ³í¹® 3,515Æí Áß¿¡¼ ÀÓ»óÀÇÇкоßÀÇ ³í¹®ÀÌ Â÷ÁöÇÏ´Â ºñÀ²Àº 1,736ÆíÀ¸·Î ÀüüÀÇ 49.4%·Î °¡Àå ³ô¾Ò´Ù. ÀÌ´Â 3¿ù ¹ßÇ¥ÇöȲ°ú ºñ±³ÇÏ¿© º¼ ¶§ ÀÓ»óÀÇÇÐºÐ¾ß ³í¹®ÀÌ 104Æí Áõ°¡ÇÏ¿´À½À» ³ªÅ¸³»¾ú´Ù. ÀÓ»óÀÇÇÐ³í¹®ÀÇ µÚ¸¦ ÀÌ¾î ±âÃÊÀÇÇÐ(1,281Æí), ¿¹¹æÀÇÇÐ/º¸°ÇÇÐ(290Æí), Ä¡ÀÇÇÐ(153Æí), °£È£ÇÐ(55Æí) ¼øÀ¸·Î ³ªÅ¸³µ´Ù. ÀÇ°úÇÐºÐ¾ß Àüü 4¿ù Çѱ¹ÀÇÇÐ³í¹®µ¥ÀÌÅͺ£À̽º (KMbase)ÀÇ Å°¿öµå¸¦ ºÐ¼®ÇÑ °á°ú´Â Side effects, DNA, female, PET, stability, carbon, BMI, Hydrogen-Ion Concentration, RNA, Interleukin-, , MicroRNAs, Chronic Obstructive Lung Disease, Nutrition Surveys, Area Under Curve, Asian Continental Ancestry Group, cognitive disorder, Polymerase Chain Reaction, Serum, cervical cancer, anticancer µîÀÇ Å°¿öµå°¡ ÀÇ°úÇкоßÀÇ »óÀ§ Å°¿öµå·Î ÃâÇöÇÏ¿´´Ù.
±×¸² 1. Çѱ¹ÀÇÇÐ³í¹®µ¥ÀÌÅͺ£À̽º Å°¿öµå ¿¬±¸µ¿ÇâºÐ¼®(KMbase 4¿ù ¹ßÇ¥±âÁØ)
Ç¥1. ÀÇ°úÇÐ ÃֽŠ¿¬±¸µ¿Ç⠺м® : ÀÇ°úÇÐ ºÐ¾ß 2019³â 4¿ù Å°¿öµå ºÐ¼®
(KMbase: Çѱ¹ÀÇÇÐ³í¹®µ¥ÀÌÅͺ£À̽º 2019³â 4¿ù Àú³Î ¹ßÇ¥±âÁØ)
Å°¿öµå ¼øÀ§
|
ÀÇ°úÇÐ ºÐ¾ß Å°¿öµå ÃâÇö
|
1
|
Side effects
|
2
|
DNA
|
3
|
female
|
4
|
PET
|
5
|
stability
|
6
|
carbon
|
7
|
BMI
|
8
|
Hydrogen-Ion Concentration
|
9
|
RNA
|
10
|
Interleukin-6
|
11
|
MicroRNAs
|
12
|
Chronic Obstructive Lung Disease
|
13
|
Nutrition Surveys
|
14
|
Area Under Curve
|
15
|
Asian Continental Ancestry Group
|
16
|
cognitive disorder
|
17
|
Polymerase Chain Reaction
|
18
|
Serum
|
19
|
cervical cancer
|
20
|
anticancer
|